Primary Aldosteronism and Cerebrovascular Diseases

논문상세정보

' Primary Aldosteronism and Cerebrovascular Diseases' 의 참고문헌

  • saline infusion test highly associated with the incidence of cardio-and cerebrovascular events in primary aldosteronism
    Hayashi R [2017]
  • Vascular actions of aldosterone
    Briet M [2013]
  • Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy : prospective study of 102 patients
    Liao CW [2016]
  • The association of carotid intima-media thickness(cIMT)and stroke : a cross sectional study
    Harris S [2012]
  • T regulatory lymphocytes prevent aldosterone-induced vascular injury
    Kasal DA [2012]
  • Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century
    Feigin VL [2003]
  • Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart
    Rocha R [2002]
  • Risk of ischemic stroke in primary aldosteronism patients
    Kao CC [2015]
  • Primary aldosteronism in patients with acute stroke : prevalence and diagnosis during initial hospitalization
    Miyaji Y [2016]
  • Primary aldosteronism : diagnostic and treatment strategies
    Mattsson C [2006]
  • Primary aldosteronism : diagnosis and management
    Gyamlani G [2016]
  • Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats
    Benetos A [1997]
  • Prevalence of cardiovascular disease and its risk factors in primary aldosteronism : a multicenter Study in Japan
    Ohno Y [2018]
  • Prevalence and diagnosis of primary aldosteronism
    Rossi GP [2010]
  • Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice
    Monticone S [2017]
  • Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism
    Murata M [2017]
  • Pathophysiology of vascular remodeling in hypertension
    Renna NF [2013]
  • Pathophysiological effects of aldosterone in cardiovascular tissues
    Rocha R [2001]
  • Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism
    Rossi GP [2013]
  • Long-term cardio-and cerebrovascular events in patients with primary aldosteronism
    Mulatero P [2013]
  • Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism
  • Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension
    Strauch B [2006]
  • Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism
    Hundemer GL [2018]
  • Global burden of stroke
    Feigin VL [2017]
  • Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
    Milliez P [2005]
  • Eplerenone : cardiovascular protection
    Brown NJ [2003]
  • Diagnosis and management ofprimary aldosteronism
    Vilela LAP [2017]
  • Conn’s syndrome and atrial fibrillation
    Porodko M [2001]
  • Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk
    Touboul PJ [2005]
  • Cardiovascular outcomes in patients with primary aldosteronism after treatment
    Catena C [2008]
  • Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension : a systematic review and meta-analysis
    Monticone S [2018]
  • Cardiovascular complications associated with primary aldosteronism : a controlled cross-sectional study
    Savard S [2013]
  • Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats
    Nakano S [2005]
  • Cardiometabolic outcomes and mortality in medically treated primary aldosteronism : a retrospective cohort study
    Hundemer GL [2018]
  • Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study
    Bjorck S [2013]
  • Atrial fibrillation in primary aldosteronism
    Watson T [2009]
  • Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism(Conn’s syndrome)
    Al-Aloul B [2006]
  • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    Wolf PA [1991]
  • Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism
    Bernini G [2008]
  • Arterial stiffness and risk of coronary heart disease and stroke : the Rotterdam Study
  • Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
    Blacher, J. [1999]
  • Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake : the Ohasama study
    Satoh M [2012]
  • Aldosterone-mediated endothelial remodeling and oxidative stress
    Calo LA [2005]
  • Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells
    Mazak I [2004]
  • Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term
    Rossi GP [2018]
  • Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma
    Lin YH [2012]
  • Adrenalectomy improves arterial stiffness in primary aldosteronism
    Strauch B [2008]